Kenyatta National Hospital (KNH) has issued a statement clarifying the circumstances surrounding the removal of a transplanted kidney from a patient, following a police report filed by the patient. The incident refers to a woman whose transplanted kidney, donated by her brother, failed under mysterious circumstances.

• KNH stated the transplant recipient was diagnosed with kidney failure in 2022.
• The transplant occurred by February 12, 2025, after which the kidney did not function due to a blood clot, a rare complication.
• The hospital removed the kidney for the patient's health after determining it was not viable, discharging her on March 5 to resume dialysis.
• KNH CEO William Sigilai noted that in the 2024/2027 Financial Year, KNH performed 22 kidney transplants, with 21 successful outcomes.

The Nairobi Hospital has suspended its recently announced price review following discussions with leading medical insurance providers. This decision, effective immediately, aims to allow for further consultations and collaborative dialogue regarding the proposed tariff adjustments.

• Insurers had warned of withdrawing services due to increases of up to 61 percent on critical services like scans, ultrasounds, and bed charges.
• The meeting included top executives from insurers such as Old Mutual, CIC, Britam Health, and AAR.
• Chief Executive Officer Felix Osano stated the decision was made in good faith following a productive strategic meeting on Monday.

The Nairobi Hospital has suspended its recently announced service price review following significant backlash from insurers and stakeholders. This decision came after 12 insurers temporarily removed the hospital from their provider panels in retaliation to proposed fee increases.

• Treatment costs were expected to rise by up to 61 per cent, prompting affordability concerns from insurers.
• The suspension was announced on August 11 after a strategic meeting between the hospital and key insurance providers.
• Internally, the hospital is reportedly facing a governance crisis, with its Board of Management, chaired by Herman Manyora, accusing the CEO and Company Secretary of making unilateral decisions, including the price hike.